Retraction: HealthLINE: A messaging chatbot for supporting chronic disease self-management - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Withdrawal Notice: HealthLINE - A Chatbot Designed to Aid Self-Management of Chronic Conditions

  • September 7, 2026

Share

Objective:

To inform about the retraction of the article titled 'HealthLINE'.

Approach:
  • Retraction Process: The article was retracted following concerns about the authenticity of the last author's affiliation.
  • Verification Attempt: The last author was contacted for verification, providing an institutional ID that had expired in 2023.
  • Institutional Confirmation: Pennsylvania State University confirmed that the last author had no current affiliation with the institution.
Key Findings:
  • The last author's identity could not be verified.
  • The article was retracted at the request of Sage and the Journal Editor.
  • M.H.H. expressed disagreement with the retraction decision.
Limitations:
  • The article's validity is compromised due to the inability to verify the last author's identity.
Conclusion:

The article has been officially retracted due to concerns about authorship.

Sources:

Original Source(s)

Retraction: HealthLINE: A messaging chatbot for supporting chronic disease self-management

  • September 7, 2026

Related Content

Estriol may ease menopause-related cognitive decline

Women reported improvement across 6 cognitive domains during 12 months of estriol-based treatment, while murine models suggested a potential astrocyte-mediated mechanism.

Inside the hip osteoarthritis microbiome

Investigators compared intra-articular microbial profiles and predicted metabolic pathways in patients with hip osteoarthritis and nonarthritic controls.

Extended antiviral therapy may not improve long COVID

Nirmatrelvir–ritonavir for up to 25 days failed to improve cognitive, autonomic, or exercise symptoms compared with placebo in a phase 2 trial.